DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Revenue History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Sales | ₹9,360 Cr | ₹7,845 Cr | ₹7,767 Cr | ₹8,960 Cr | ₹6,969 Cr |
What is the latest Revenue of DIVIS LABORATORIES ?
Year | Revenue |
---|---|
Mar2025 | ₹9,360 Cr |
Mar2024 | ₹7,845 Cr |
Mar2023 | ₹7,767 Cr |
Mar2022 | ₹8,960 Cr |
Mar2021 | ₹6,969 Cr |
How is Revenue of DIVIS LABORATORIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹9,360 Cr | 19.31 | |
Mar2024 | ₹7,845 Cr | 1.00 | |
Mar2023 | ₹7,767 Cr | -13.31 | |
Mar2022 | ₹8,960 Cr | 28.56 | |
Mar2021 | ₹6,969 Cr | - |
Compare Revenue of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹175,726.5 Cr | 1% | 9.4% | 8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,872.0 Cr | 0.6% | 3.6% | -12.5% | Stock Analytics | |
CIPLA | ₹127,449.0 Cr | 0.9% | 1.2% | -0.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,125.0 Cr | 1.7% | 1% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,827.0 Cr | -0.5% | -4.2% | -6.3% | Stock Analytics | |
MANKIND PHARMA | ₹102,292.0 Cr | 1.5% | -3.5% | -10.6% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 1% |
9.4% |
8% |
SENSEX | 1.8% |
1.9% |
2.4% |
You may also like the below Video Courses